Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed – an update about the clinical development of IBP-9414

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing